Literature DB >> 8919324

A prospective 1-5 year outcome study in first-admitted and readmitted schizophrenic patients; relationship to heredity, premorbid adjustment, duration of disease and education level at index admission and neuroleptic treatment.

I M Wieselgren1, L H Lindstrom.   

Abstract

In a prospective outcome study, 120 DSM-III-R schizophrenic patients were followed for up to 5 years after index admission, when a comprehensive clinical and demographical examination was undertaken with the aim to find early prognostic factors for outcome. They were 86 males (72%) and 34 females (28%), and 66 (55%) were first-admitted and never before treated at index admission from a geographically defined area. Outcome was evaluated 1, 3 and 5 years after index admission by use of a Strauss-Carpenter outcome scale. At year five, 101 patients could be evaluated. Seven (7%) patients had committed suicide during the 5 years' follow-up period. 30% of the patients was considered to have a good, 14% a poor and 56% an intermediate outcome. It was found that 58% had not been in hospital during the last year, 27% were employed on the open market, 25% met friends regularly and 38% had no or only mild symptoms at the five years' follow-up evaluation. Females had a significantly better outcome than males. High education level and absence of premorbid deviant behaviour at index admission predicted a good outcome whereas problems in school (with friends and/or teachers) reported by relatives predicted poor outcome. No relationship was found between outcome and age at onset of the disorder and no gender difference in age at onset of the disorder. Patients with a family history of schizophrenia improved more between year one and five as compared with those without a family history, but heredity in itself was not an important factor for outcome. At 5 years after index admission, 40% of patients were on classical neuroleptics and 33% on clozapine whereas 19% were without medication. Of the total sample of 101 patients, 10% were drug-free and had a very good outcome at the 5 years' evaluation. The data indicate that there is a substantial subgroup of schizophrenic patients with a good prognosis and they can be characterized by female sex (even in a group without gender difference in age at onset), absence of premorbid deviant behaviour and a high education level at index admission.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8919324     DOI: 10.1111/j.1600-0447.1996.tb10613.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  11 in total

1.  Demographic correlates of attenuated positive psychotic symptoms.

Authors:  Rachel N Waford; Allison MacDonald; Katrina Goines; Derek M Novacek; Hanan D Trotman; Walker Elaine F; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Daniel H Mathalon; Ming T Tsuang; Diana O Perkins; Larry J Seidman; Scott W Woods; Thomas H McGlashan
Journal:  Schizophr Res       Date:  2015-05-18       Impact factor: 4.939

Review 2.  The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.

Authors:  Marc De Hert; Jan Sermon; Paul Geerts; Kristof Vansteelandt; Joseph Peuskens; Johan Detraux
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

3.  Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis.

Authors:  J F Guest; R F Cookson
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

4.  Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders.

Authors:  Malin Alenius; Margareta Hammarlund-Udenaes; Per Hartvig; Leif Lindström
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-07-21       Impact factor: 4.328

5.  Patient Characteristics, Length of Stay, and Functional Improvement for Schizophrenia Spectrum Disorders: A Population Study of Inpatient Care in Ontario 2005 to 2015.

Authors:  Sheng Chen; April Collins; Kelly Anderson; Kwame McKenzie; Sean Kidd
Journal:  Can J Psychiatry       Date:  2016-12-14       Impact factor: 4.356

6.  Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up.

Authors:  Raimo K R Salokangas; Dorien H Nieman; Markus Heinimaa; Tanja Svirskis; Sinikka Luutonen; Tiina From; Heinrich Graf von Reventlow; Georg Juckel; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Frauke Schultze-Lutter; Joachim Klosterkötter; Stephan Ruhrmann
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-07-15       Impact factor: 4.328

7.  Treatment-refractory schizophrenia.

Authors:  Asaf Caspi; Michael Davidson; Carol A Tamminga
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

8.  The revolving door phenomenon revisited: time to readmission in 17’145 [corrected] patients with 37'697 hospitalisations at a German psychiatric hospital.

Authors:  Ulrich Frick; Hannah Frick; Berthold Langguth; Michael Landgrebe; Bettina Hübner-Liebermann; Göran Hajak
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

9.  Predictors of psychiatric rehospitalization among elderly patients.

Authors:  Chun Yin Terry Wong
Journal:  F1000Res       Date:  2015-09-30

10.  Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics.

Authors:  Yi-Lung Chen; Kun-Po Chen; Chih-Chiang Chiu; Ming-Hong Tai; For-Wey Lung
Journal:  BMC Psychiatry       Date:  2018-12-04       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.